43 terminated. 43 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 43 | Terminated 43 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy Sugammadex, Neostigmine/Glycopyrrolate - Appendicitis, Surgery | Phase 4 | Terminated | Emory University | 22 | 2023-07-19 | 2025-09-30 |
| Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF Multiple standard of care antibiotics for appendicitis, at physicians' discretion - Appendicitis | Phase 4 | Terminated | University of California, San Francisco | 42 | 2023-06-06 | 2026-10-27 |
| An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice Ozanimod - Colitis, Ulcerative | Phase 4 | Terminated | Bristol-Myers Squibb | 139 | 2022-12-16 | 2026-02-10 |
| Pilot Study of Posaconazole in Crohn's Disease Posaconazole Delayed Release Oral Tablet, Matching Placebo Tablet - Crohn Disease, CARD9 S12N Risk Allele | Phase 4 | Terminated | Cedars-Sinai Medical Center | 10 | 2022-08-17 | 2026-02-24 |
| Induction Optimization With Stelara for Crohn's Disease Ustekinumab - Crohn Disease | Phase 4 | Terminated | NYU Langone Health | 12 | 2022-02-16 | 2024-11-05 |
| Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). Bezlotoxumab - Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 4 | Terminated | David Binion, MD | 19 | 2021-10-14 | 2025-06-05 |
| A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula Darvadstrocel - Crohn's Disease, Complex Perianal Fistula | Phase 4 | Terminated | Takeda | 53 | 2020-12-22 | 2026-01-22 |
| Efficacy and Safety of Teicoplanin in CDAD TEICOPLANIN - Clostridium Difficile Infection-associated Diarrhea and Colitis | Phase 4 | Terminated | Sanofi | 50 | 2020-05-15 | 2025-09-23 |
| Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. Amgevita 40Mg Solution for Injection, HUMIRA 40Mg Solution for Injection - Crohn Disease, Ulcerative Colitis | Phase 4 | Terminated | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 24 | 2019-10-10 | 2021-01-12 |
| TITRATE (inducTIon for acuTe ulceRATivE Colitis) Infliximab - Colitis, Ulcerative | Phase 4 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 50 | 2019-09-04 | 2025-02-06 |
| Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery. Bezlotoxumab, Normal Saline - Clostridia Difficile Colitis, Clostridium; Sepsis | Phase 4 | Terminated | Ohio State University | 5 | 2019-08-19 | 2026-06-18 |
| Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib SHINGRIX - Inflammatory Bowel Diseases | Phase 4 | Terminated | Boston Medical Center | 15 | 2019-07-31 | 2025-02-21 |
| Antibiotic Duration in Post-appendectomy Abscess ampicillin/clavulanate - Complicated Appendicitis, Perforated Appendicitis | Phase 4 | Terminated | Phoenix Children's Hospital | 7 | 2019-05-01 | 2024-03-08 |
| Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD) Prednisone, Exclusive Enteral Nutrition - Crohn's Disease | Phase 4 | Terminated | McMaster University | 3 | 2018-10-25 | 2020-09-02 |
| Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis Methylprednisolone, Prednisone - Ulcerative Colitis | Phase 4 | Terminated | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 75 | 2018-10-11 | 2026-06-02 |
| A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission CP-690,500 5 mg, CP-690,550 10 mg - Ulcerative Colitis | Phase 4 | Terminated | Pfizer | 140 | 2017-11-16 | 2023-03-21 |
| Ultrasound Evaluation of Crohn's Disease Sulfur Hexafluoride, Ultrasound Elastography, Ultrasound Vascularity - Crohn Disease | Phase 4 | Terminated | Mayo Clinic | 9 | 2017-06-16 | 2021-11-10 |
| Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease Vedolizumab - Colitis, Ulcerative, Crohn Disease | Phase 4 | Terminated | Takeda | 331 | 2016-08-01 | 2023-11-18 |
| Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease Vedolizumab - Crohn Disease | Phase 4 | Terminated | Centre Hospitalier Universitaire de Saint Etienne | 47 | 2016-07-01 | 2023-06-15 |
| An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease Infliximab - Inflammatory Bowel Diseases | Phase 4 | Terminated | Janssen Scientific Affairs, LLC | 53 | 2016-04-01 | 2025-02-04 |
Showing 20 of 43. Sign in to see all of them.
Crohn Disease (19) · Colitis, Ulcerative (14) · Inflammatory Bowel Diseases (9) · Appendicitis (5) · Enterocolitis, Pseudomembranous (2) · Infections (2) · Bacteremia (1) · Clostridium Infections (1) · Colitis (1) · Cystitis (1) · Cystitis, Interstitial (1) · Dehydration (1) · Eosinophilic Esophagitis (1) · Gastroesophageal Reflux (1)
Digestive System Diseases (43) · Gastrointestinal Diseases (43) · Intestinal Diseases (41) · Inflammatory Bowel Diseases (24) · Colonic Diseases (15) · Colitis (14) · Infections (7) · Pathological Conditions, Signs and Symptoms (6) · Cecal Diseases (5) · Intraabdominal Infections (5) · Pathologic Processes (4) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3)
Infliximab (5) · Prednisone (4) · Azathioprine (3) · vedolizumab (3) · Adalimumab (2) · Adrenal Cortex Hormones (2) · Methylprednisolone (2) · Saline Solution (2) · bezlotoxumab (2) · Amoxicillin-Potassium Clavulanate Combination (1) · Ampicillin (1) · Anesthesia, General (1) · BID protein, human (1) · CT-P13 (1) · Celecoxib (1)
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (2) · Pfizer (2) · Takeda (2) · University of Western Ontario, Canada (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Asahi Kasei Medical Co., Ltd. (1) · Baxter Healthcare Corporation (1) · Beth Israel Medical Center (1) · Boston Medical Center (1) · Bristol-Myers Squibb (1) · Cedars-Sinai Medical Center (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Dallas VA Medical Center (1) · David Binion, MD (1) · Emory University (1)
United States (22) · Germany (5) · Spain (5) · Canada (4) · Czechia (4) · France (4) · Italy (4) · Israel (3) · Netherlands (3) · South Korea (3) · Austria (2) · Hungary (2) · India (2) · Ireland (2) · Japan (2)
Aharon Lerner, MD (1) · Arie Levine, MD (1) · Avi On, MD (1) · Baruch Yerushalmi, MD (1) · Batia Weiss, MD (1) · Brian Feagan, MD (1) · Brian G Feagan, MD (1) · Bruce E Sands, MD, MS (1) · Craig Egan, MD (1) · Dan Turner, MD, PhD (1)
PMID 24953836, PMID 27480410, PMID 33210333, PMID 35648151, PMID 36124702, PMID 38425446, PMID 38778549, PMID 40013523, PMID 40028509, PMID 40357993, PMID 41258993, PMID 41684725, PMID 42669025
2016 (2), 2017 (2), 2009 (1), 2014 (1), 2015 (1), R01DK125495 (1)